Skip to main content

Table 1 Characteristics of patients undergoing lobectomy

From: Atrial fibrillation and alteration of heart rate variability after video-assisted pulmonary lobectomy versus thoracotomy pulmonary lobectomy

Variables VATS (n = 112) THORAC (n = 112) P value
Clinical data
 Age (mean ± SD, years) 71 ± 8 71 ± 6 0.95
 Male (%) 71 (63.4) 69 (61.7) 0.79
 Smoking (%) 67 (59.8) 65 (58.0) 0.75
 Hypertension (%) 35 (31.3) 32 (28.5) 0.78
 CAD (%) 18 (16.1) 16 (14.3) 0.81
 β-blockage 16 (14.2) 15 (13.4) 0.61
 Diabetes (%) 12 (10.7) 10 (8.9) 0.67
 Chemotherapy (%) 16 (14.3) 13 (11.6) 0.59
Heart rate (beats/min) 70 ± 12 72 ± 13 0.89
 Pulmonary function
  FVC (%) 90 ± 27 97 ± 22 0.56
  FEV1 (%) 86 ± 22 85 ± 20 0.63
 Surgical procedure
  Right lobectomy (%) 47 (42) 45 (40.2) 0.82
  Left lobectomy (%) 65 (58) 67 (59.8) 0.72
Pathology (%)
  Adenocarcinoma 52 (46.4) 48 (42.8) 0.58
  Squamous carcinoma 49 (43.7) 52 (46.4) 0.42
  Small cell lung carcinoma 6 (5.4) 5 (4.5) 0.32
  Large cell lung carcinoma 5 (4.5) 7 (6.3) 0.28
 Postoperative complication
  Atrial fibrillation (%) 19 (16.9) 20 (17.9) 0.79
  Pneumonia (%) 2 (1.7) 3 (2.6) 0.73
 Atelectasis (%) 6 (5.2) 8 (7.1) 0.61
 Air leak duration (%) 14 (12.5) 12 (12.7) 0.71
 Length of stay in hospital (days) 7.5 ± 3.2 13.6 ± 4.1 < 0.005